TKT and herpes simplex encephalitis: This mutation has been identified in an intrathecal ACVR HSV-1 isolate from an HSE patient refractory to ACV therapy [16] and we have previously shown that a recombinant HSV-1 TK protein containing R41H did not convert ACV to ACV-monophosphate in vitro [30].